The University of Manchester (UK) has a particular interest in graphene as the material was isolated by future Nobel Prize winners, Andre Gheim and Kostya (Konstantin) Novoselov in the university’s laboratories. There’s a Feb. 18, 2013 news item on Nanowerk highlighting the university’s past and future role in the development of graphene on the heels of the recent research bonanza,

The European Commission has announced that it is providing 1bn euros over 10 years for research and development into graphene – the ‘wonder material’ isolated at The University of Manchester by Nobel Prize winners Professors Andre Geim and Kostya Novoselov.

The University is very active in technology transfer and has an excellent track-record of spinning out technology, but some think that the University has taken a different view when it comes to patenting and commercialising graphene. Others have expressed a broader concern about British Industry lagging behind in the graphene ‘race’, based upon international ‘league tables’ of numbers of graphene patents.

A recent interview with Clive Rowland (CEO of the University’s Innovation Group) addresses the assumptions about the University’s approach and reflects more generally about graphene patenting and about industry up-take of graphene. The interview is summarised below.

Question: Has the University set up any commercial graphene activities?

Answer: The University owns a company, called 2-DTech Limited, which makes and supplies two-dimensional materials and has an interest in another, Graphene Industries Limited, which sells graphene made by a different technique to 2-DTech.

Question: Is the University falling behind in graphene?

Answer: The University is the world’s leading university for graphene research and publications. It led the charge for UK investment into the field and has been awarded The National Graphene Institute, which will be a £61m state-of-the art centre. This Institute will act as a focus for all sorts of commercial graphene activity in Manchester, from industrial research and development laboratories locating “alongside” the Institute, developing new processes and products, to start-up companies. The University championed the major flagship research funding programmes that have been initiated in the UK and Europe and has been awarded a number of prestigious grants. Graphene is still a science-driven research field and not yet a commercialised technology.

The rest of the summary can be found either at Nanowerk or in this University of Manchester Feb. 18, 2013 news release.

The University of Manchester Innovation Group (aka UMI³) mentioned in connection with Clive Rowland hosts the complete interview (12 pp), which, read from the beginning, provides an enhanced perspective on the university’s graphene commercialization goals,

Graphene – The University of Manchester and Intellectual Property. Dan Cochlin talks to Clive Rowland – The University’s InnovationGroup CEO —‐ about the launch of a new grapheme company at the University, 2–‐DTech Ltd, And grapheme patents and commercialisation.

What is grapheme and why is there so much interest in it?

Graphene is a revolutionary nano material which was first isolated at The University of Manchester By Professors Andre Geim And Konstantin Novoselov. They received the Nobel Prize in 2010 For their ingenious work on graphene. People are excited about it because it has the potential to transform a vast range of products due to its very superior capabilities compared to existing materials.

So what’s the new company about?

It makes and sells CVD graphene, grapheme platelets, grapheme oxide and other advanced materials with amazing properties, which are being called 2–‐D – two dimensional – due to  their single atomic layer thickness. In other words, they’re so thin it’s as if they only have length and breadth dimensions. It will soon have an e–‐commerce site too, where customers can shop on–‐line. The Company will create and develop intellectual property, especially by engaging in interesting assignments such as collaborating with firms on design projects. It will also provide consulting services ,in the field, either directly or by sub–‐contracting to our relevant academic colleagues here at the University. We’re already an international team – with Antiguan, British and Italian people actively involved in the business and a fast developing business agency network in the Far East and the USA.

What’s CVD?

It’s one of the techniques for making grapheme that 2-DTech uses –‐ chemical vapour deposition –‐ which allows us to grow grapheme on foils and films in quite large area sizes for various potential uses, particularly information technology and communications because of graphene’s high quality and unique electronic transport, flexibility and other astounding attributes.

Well why have you only just set this up when others have been doing so for a while now?

The University’s researchers in physics and materials science have been able to make enough grapheme for their own needs until lately, but not any longer. Besides, there has been an expansion of interest across the University in the potential of the material, including from areas such as health and bio–‐sciences. Hence we want to make sure that the University has a regular supply for those colleagues who cannot continue to make it in sufficient quantities or who aren’t familiar with the material.

In addition many of the companies in contact with the University’s Researchers are in a similarly constrained position. So we feel the need to have a University Facility to handle this which is free of the normal academic duties and interests. At the same time we see an international business opportunity.

There’s a strong market demand for high quality grapheme of a consistent nature and a growing interest in other 2–‐D crystals. A number of researchers, especially our CTO Dr Branson Belle, who had been researching 2–‐D Materials and making grapheme for a long time became interested in the business side. …

Thank you Clive Rowland and the University of Manchester for insight into the graphene commercialization efforts on the part of at least one university.  Meanwhile, the comment about producing enough graphene for research reminds me of the queries I get from entrepreneurs about getting access to nanocrystalline cellulose (NCC) or cellulose nanocrystals (CNC). To my knowledge, no one outside the research community has gotten access to the materials. I wonder if despite the fact there are two manufacturing facilities whether this may be due to an inability to produce enough CNC or NCC.